Ublituximab

Names

[ Name ]:
Ublituximab

Biological Activity

[Description]:

Ublituximab (LFB-R603; TG-1101; TGTX-1101) is a next-generation, type 1 chimeric monoclonal antibody targeting a unique epitope on the CD20 antigen. Ublituximab has anticancer effects[1].

[Related Catalog]:

Research Areas >> Cancer

[In Vitro]

Ublituximab 经过糖工程改造，具有含低岩藻糖的可结晶片段 (Fc) 区域，可增强抗体依赖性细胞毒性[1]。

[References]

[1]. Matthew Lunning, et al. Ublituximab and umbralisib in relapsed/refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia. Blood. 2019 Nov 21;134(21):1811-1820.

Chemical & Physical Properties

No Any Chemical & Physical Properties

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.